Surmann Hanna, Kiesel Ludwig
Department of Gynecology and Obstetrics, University of Muenster, Albert-Schweitzer Campus 1, 48149 Münster, Germany.
Int J Mol Sci. 2025 Jun 19;26(12):5862. doi: 10.3390/ijms26125862.
Endometriosis, affecting up to 10% of women in their reproductive years, is a chronic and multifactorial disease characterized by the presence of endometrial tissue outside the uterus. Traditionally associated with pain and infertility, recent studies highlight its systemic nature, implicating inflammatory, immunological, and hormonal dysregulation in its pathogenesis. This paper explores the emerging role of microRNAs (miRNAs) in the pathophysiology of endometriosis and its related infertility. Evidence suggests that dysregulation of specific miRNAs influences cellular proliferation, migration, and progesterone resistance, thereby contributing to the development and progression of endometriotic lesions. Additionally, altered miRNA expression profiles hold promise as non-invasive biomarkers for improving diagnostic accuracy and as potential targets for novel therapeutic interventions. Although current diagnostic methods, such as laparoscopy, remain the gold standard, the integration of miRNA-based approaches could reduce reliance on invasive procedures and enhance treatment outcomes. Ultimately, further research-particularly regarding the interplay between endometriosis and infertility-is crucial to fully elucidate these complex mechanisms and foster the development of more effective diagnostic and therapeutic strategies.
子宫内膜异位症影响着高达10%的育龄女性,是一种慢性多因素疾病,其特征是子宫外存在子宫内膜组织。传统上与疼痛和不孕相关,最近的研究突出了其全身性本质,表明炎症、免疫和激素失调在其发病机制中起作用。本文探讨了微小RNA(miRNA)在子宫内膜异位症及其相关不孕的病理生理学中的新作用。有证据表明,特定miRNA的失调会影响细胞增殖、迁移和孕激素抵抗,从而促进子宫内膜异位病变的发展和进展。此外,改变的miRNA表达谱有望作为提高诊断准确性的非侵入性生物标志物以及新型治疗干预的潜在靶点。尽管目前的诊断方法,如腹腔镜检查,仍然是金标准,但基于miRNA的方法的整合可以减少对侵入性程序的依赖并改善治疗效果。最终,进一步的研究——特别是关于子宫内膜异位症与不孕之间的相互作用——对于充分阐明这些复杂机制并促进更有效的诊断和治疗策略的发展至关重要。